Oral anticoagulant therapy: should doctors change the way they give patients explanations ?

• References

• 1 Laporte S, Quenet S, Buchmuller-Cordier A. et al. Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost 2003; 89: 458-67.
• 2 Pattaccini C, Tagliaferri A, Manotti C. Awarness of teratogenic effect of oral anticoagulants in fertile women. Thromb Haemost 2002; 88: 172
• 3 Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. Haematologica 2002; 87: 1081-86.
• 4 Barcellona D, Contu P, Sorano GG. et al. The management of oral anticoagulant therapy: the patient’s point of view. Thromb Haemost 2000; 83: 49-53.
• 5 Barcellona D, Vannini ML, Fenu L. et al. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants ?. Thromb Haemost 1998; 80: 899-902.